Polysialic Acid and Polysialylation to Modulate Antibody Pharmacokinetics

Therapeutic Proteins: Strategies to Modulate Their Plasma Half-Lives

Volumn , Issue , 2012, Pages 95-115

  Constantinou, Antony ^a   Chen, Chen ^a   Deonarain, Mahendra P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody; Conjugation; Half life extension; Immunogenicity; Pharmacokinetics; Polysialic acid; Polysialylation; Therapeutic proteins

Indexed keywords

EID: 84886204105     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527644827.ch6     Document Type: Chapter

References (123)

1. Knop, K., Hoogenboom, R., Fischer, D., and Schubert, U.S. (2010) Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. Engl., 49 (36), 6288-6308.
2. Bendele, A., Seely, J., Richey, C., Sennello, G., and Shopp, G. (1998) Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins. Toxicol. Sci, 42 (2), 152-157.
3. Gaberc-Porekar, V., Zore, I., Podobnik, B., and Menart, V. (2008) Obstacles and pitfalls in the PEGylation of therapeutic proteins . Curr. Opin. Drug Discov. Devel., 11 (2), 242-250.
4. Armstrong, J.K., Hempel, G., Koling, S., Chan, L.S., Fisher, T., Meiselman, H.J., and Garratty, G. (2007) Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer, 110 (1), 103-111.
5. Riley, S. (2006) Innovation in drug delivery: the future of nanotechnology and non-invasive protein delivery. Business Insights Report, 2006 (Business Insights Ltd).
6. Toikka, J., Aalto, J., Hayrinen, J., Pelliniemi, L.J., and Finne, J. (1998) The polysialic acid units of the neural cell adhesion molecule N-CAM form filament bundle networks. J. Biol. Chem, 273 (44), 28557-28559.
7. Taylor, M.E., and Drickamer, K. (2006) Introduction to Glycobiology, 2nd edn, Oxford University Press, pp. 26-28.
8. Azurmendi, H.F., Vionnet, J., Wrightson, L., Trinh, L.B., Shiloach, J., and Freedberg, D.I. (2007) Extracellular structure of polysialic acid explored by on cell solution NMR . Proc. Natl. Acad. Sci. U.S.A., 104 (28), 11557-11561.
9. Fernandes, A.I., and Gregoriadis, G. (1996) Synthesis, characterization and properties of sialylated catalase. Biochim. Biophys. Acta, 1293 (1), 90-96.
10. Constantinou, A., Epenetos, A.A., Hreczuk-Hirst, D., Jain, S., and Deonarain, M.P. (2008) Modulation of antibody pharmacokinetics by chemical polysialylation. Bioconjug. Chem., 19 (3), 643-650.
11. Constantinou, A., Epenetos, A.A., Hreczuk-Hirst, D., Jain, S., Wright, M., Chester, K.A., and Deonarain, M.P. (2009) Site-specific polysialylation of an antitumor single-chain Fv fragment. Bioconjug. Chem., 20 (5), 924-931.
12. Sasahara, K. (1995) Temperature dependence of volume changes on glycine-PEG and L-alanine-PEG in aqueous solution. Colloid. Polym. Sci., 273 (8), 782-786.
13. Antonsen, K.P., and Hoffman, A.S. (1992) Water structure of PEG solutions by differential scanning calorimetry measurement, in Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications (ed. J.M. Harris), Plenum Press, New York, pp. 15-28.
14. Harris, J.M., and Chess, R.B. (2003) Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov., 2 (3), 214-221.
15. Fee, C.J., and Van Alstine, J.M. (2004) Prediction of the viscosity radius and the size exclusion chromatography behavior of PEGylated proteins. Bioconjug. Chem., 15 (6), 1304-1313.
16. Deen, W.M., Bohrer, M.P., and Brenner, B.M. (1979) Macromolecule transport across glomerular capillaries: application of pore theory. Kidney Int., 16 (3), 353-365.
17. Fernandes, A.I., and Gregoriadis, G. (1997) Polysialylated asparaginase: preparation, activity and pharmacokinetics. Biochim. Biophys. Acta, 1341 (1), 26-34.
18. Jain, S., Hreczuk-Hirst, D., Laing, P., and Gregoriadis, G. (2004) Polysialylation: the natural way to improve the stability and pharmacokinetics of protein and peptide drugs. Drug Deliv. Syst. Sci., 4 (1), 3-9.
19. Pavlinkova, G., Beresford, G., Booth, B.J., Batra, S.K., and Colcher, D. (1999) Charge-modified single chain antibody constructs of monoclonal antibody CC49: generation, characterization, pharmacokinetics, and biodistribution analysis. Nucl. Med. Biol., 26 (1), 27-34.
20. Onda, M., Nagata, S., Tsutsumi, Y., Vincent, J.J., Wang, Q., Kreitman, R.J., Lee, B., and Pastan, I. (2001) Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activity. Cancer Res., 61 (13), 5070-5077.
21. Kim, I., Kobayashi, H., Yoo, T.M., Kim, M.K., Le, N., Han, E.S., Wang, Q.C., Pastan, I., Carrasquillo, J.A., and Paik, C.H. (2002) Lowering of pI by acylation improves the renal uptake of 99mTc-labeled anti-Tac dsFv: effect of different acylating reagents. Nucl. Med. Biol., 29 (8), 795-801.
22. Kim, I.S., Yoo, T.M., Kobayashi, H., Kim, M.K., Le, N., Wang, Q.C., Pastan, I., Carrasquillo, J.A., and Paik, C.H. (1999) Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with 99mTc. Bioconjug. Chem., 10 (3), 447-453.
23. Lee, H.J., and Pardridge, W.M. (2003) Monoclonal antibody radiopharmaceuticals: cationization, PEGylation, radiometal chelation, pharmacokinetics, and tumor imaging. Bioconjug. Chem., 14 (3), 546-553.
24. Dellian, M., Yuan, F., Trubetskoy, V.S., Torchilin, V.P., and Jain, R.K. (2000) Vascular permeability in a human tumor xenograft: molecular charge dependence. Br. J. Cancer, 82 (9), 1513-1518.
25. Behr, T.M., Becker, W.S., Sharkey, R.M., Juweid, M.E., Dunn, R.M., Bair, H.J., Wolf, F.G., and Goldenberg, D.M. (1996) Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J. Nucl. Med., 37 (5), 829-833.
26. Woitas, R.P., and Morioka, T. (1996) Influence of isoelectric point on glomerular deposition of antibodies and immune complexes. Nephron, 74 (4), 713-719.
27. Behr, T.M., Sharkey, R.M., Juweid, M.E., Blumenthal, R.D., Dunn, R.M., Griffiths, G.L., Bair, H.J., Wolf, F.G., Becker, W.S., and Goldenberg, D.M. (1995) Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res., 55 (17), 3825-3834.
28. Muhlenhoff, M., Eckhardt, M., and Gerardy-Schahn, R. (1998) Polysialic acid: three-dimensional structure, biosynthesis and function. Curr. Opin. Struct. Biol., 8 (5), 558-564.
29. Bliss, J.M., and Silver, R.P. (1996) Coating the surface: a model for expression of capsular polysialic acid in Escherichia coli K1. Mol. Microbiol., 21 (2), 221-231.
30. Russo, T.A., Wenderoth, S., Carlino, U.B., Merrick, J.M., and Lesse, A.J. (1998) Identification, genomic organization, and analysis of the group III capsular polysaccharide genes kpsD, kpsM, kpsT, and kpsE from an extraintestinal isolate of Escherichia coli (CP9, O4/K54/H5). J. Bacteriol., 180 (2), 338-349.
31. Kiss, J.Z., and Rougon, G. (1997) Cell biology of polysialic acid. Curr. Opin. Neurobiol., 7 (5), 640-646.
32. Vogel, U., Weinberger, A., Frank, R., Muller, A., Kohl, J., Atkinson, J.P., and Frosch, M. (1997) Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect. Immun., 65 (10), 4022-4029.
33. Jarvis, G.A. (1995) Recognition and control of neisserial infection by antibody and complement. Trends Microbiol., 3 (5), 198-201.
34. Ferrero, M.A., and Aparicio, L.R. (2010) Biosynthesis and production of polysialic acids in bacteria. Appl. Microbiol. Biotechnol., 86 (6), 1621-1635.
35. Orskov, F., Orskov, I., Sutton, A., Schneerson, R., Lin, W., Egan, W., Hoff, G.E., and Robbins, J.B. (1979) Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. J. Exp. Med., 149 (3), 669-685.
36. Vimr, E.R., and Steenbergen, S.M. (2006) Mobile contingency locus controlling Escherichia coli K1 polysialic acid capsule acetylation. Mol. Microbiol., 60 (4), 828-837.
37. Finne, J. (1982) Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain. J. Biol. Chem., 257 (20), 11966-11970.
38. Zuber, C., Lackie, P.M., Catterall, W.A., and Roth, J. (1992) Polysialic acid is associated with sodium channels and the neural cell adhesion molecule N-CAM in adult rat brain. J. Biol. Chem., 267 (14), 9965-9971.
39. Rutishauser, U., and Landmesser, L. (1996) Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions. Trends Neurosci., 19 (10), 422-427.
40. James, W.M., and Agnew, W.S. (1987) Multiple oligosaccharide chains in the voltage-sensitive Na channel from electrophorus electricus: evidence for alpha-2, 8-linked polysialic acid. Biochem. Biophys. Res. Commun., 148 (2), 817-826.
41. Rutishauser, U. (2008) Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat. Rev. Neurosci., 9 (1), 26-35.
42. Galuska, S.P., Rollenhagen, M., Kaup, M., Eggers, K., Oltmann-Norden, I., Schiff, M., Hartmann, M., Weinhold, B., Hildebrandt, H., Geyer, R., Muhlenhoff, M., and Geyer, H. (2010) Synaptic cell adhesion molecule SynCAM 1 is a target for polysialylation in postnatal mouse brain. Proc. Natl. Acad. Sci. U.S.A., 107 (22), 10250-10255.
43. Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E.T., and Sudhof, T.C. (2002) SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science, 297 (5586), 1525-1531.
44. Stagi, M., Fogel, A.I., and Biederer, T. (2010) SynCAM 1 participates in axo-dendritic contact assembly and shapes neuronal growth cones. Proc. Natl. Acad. Sci. U.S.A., 107 (16), 7568-7573.
45. Giza, J., and Biederer, T. (2010) Polysialic acid: a veteran sugar with a new site of action in the brain. Proc. Natl. Acad. Sci. U.S.A., 107 (23), 10335-10336.
46. Yabe, U., Sato, C., Matsuda, T., and Kitajima, K. (2003) Polysialic acid in human milk. CD36 is a new member of mammalian polysialic acid-containing glycoprotein. J. Biol. Chem., 278 (16), 13875-13880.
47. Sampson, M.J., Davies, I.R., Braschi, S., Ivory, K., and Hughes, D.A. (2003) Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. Atherosclerosis, 167 (1), 129-134.
48. Harshyne, L.A., Zimmer, M.I., Watkins, S.C., and Barratt-Boyes, S.M. (2003) A role for class A scavenger receptor in dendritic cell nibbling from live cells. J. Immunol., 170 (5), 2302-2309.
49. Tandon, N.N., Kralisz, U., and Jamieson, G.A. (1989) Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem., 264 (13), 7576-7583.
50. Aiken, M.L., Ginsberg, M.H., Byers-Ward, V., and Plow, E.F. (1990) Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression. Blood, 76 (12), 2501-2509.
51. Rigotti, A., Acton, S.L., and Krieger, M. (1995) The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem., 270 (27), 16221-16224.
52. Endemann, G., Stanton, L.W., Madden, K.S., Bryant, C.M., White, R.T., and Protter, A.A. (1993) CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem., 268 (16), 11811-11816.
53. Febbraio, M., Abumrad, N.A., Hajjar, D.P., Sharma, K., Cheng, W., Pearce, S.F., and Silverstein, R.L. (1999) A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem., 274 (27), 19055-19062.
54. Karlsson, K.A. (1998) Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Mol. Microbiol., 29 (1), 1-11.
55. Morgan, B.L., and Winick, M. (1980) Effects of environmental stimulation on brain N-acetylneuraminic acid content and behavior. J. Nutr., 110 (3), 425-432.
56. Carlson, S.E., and House, S.G. (1986) Oral and intraperitoneal administration of N-acetylneuraminic acid: effect on rat cerebral and cerebellar N-acetylneuraminic acid. J. Nutr., 116 (5), 881-886.
57. Curreli, S., Arany, Z., Gerardy-Schahn, R., Mann, D., and Stamatos, N.M. (2007) Polysialylated neuropilin-2 is expressed on the surface of human dendritic cells and modulates dendritic cell-T lymphocyte interactions. J. Biol. Chem., 282 (42), 30346-30356.
58. Geretti, E., Shimizu, A., and Klagsbrun, M. (2008) Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis . Angiogenesis, 11 (1), 31-39.
59. Pellet-Many, C., Frankel, P., Jia, H., and Zachary, I. (2008) Neuropilins: structure, function and role in disease . Biochem. J., 411 (2), 211-226.
60. Bax, M., van Vliet, S.J., Litjens, M., Garcia-Vallejo, J.J., and van Kooyk, Y. (2009) Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells. PLoS ONE, 4 (9), e6987.
61. Rey-Gallardo, A., Escribano, C., Delgado-Martin, C., Rodriguez-Fernandez, J.L., Gerardy-Schahn, R., Rutishauser, U., Corbi, A.L., and Vega, M.A. (2010) Polysialylated neuropilin-2 enhances human dendritic cell migration through the basic C-terminal region of CCL21. Glycobiology, 20 (9), 1139-1146.
62. Kaneko, Y., Nimmerjahn, F., and Ravetch, J.V. (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science, 313 (5787), 670-673.
63. Close, B.E., and Colley, K.J. (1998) In vivo autopolysialylation and localization of the polysialyltransferases PST and STX. J. Biol. Chem., 273 (51), 34586-34593.
64. Maness, P.F., and Schachner, M. (2007) Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat. Neurosci., 10 (1), 19-26.
65. Pekcec, A., Weinhold, B., Gerardy-Schahn, R., and Potschka, H. (2010) Polysialic acid affects pathophysiological consequences of status epilepticus. Neuroreport, 21 (8), 549-553.
66. Garcia-Morales, I., de la Pena Mayor, P., and Kanner, A.M. (2008) Psychiatric comorbidities in epilepsy: identification and treatment. Neurologist, 14 (6 Suppl. 1), S15-S25.
67. Figarella-Branger, D., Dubois, C., Chauvin, P., De Victor, B., Gentet, J.C., and Rougon, G. (1996) Correlation between polysialic-neural cell adhesion molecule levels in CSF and medulloblastoma outcomes. J. Clin. Oncol., 14 (7), 2066-2072.
68. Gluer, S., Schelp, C., von Schweinitz, D., and Gerardy-Schahn, R. (1998) Polysialylated neural cell adhesion molecule in childhood rhabdomyosarcoma. Pediatr. Res., 43 (1), 145-147.
69. Hildebrandt, H., Becker, C., Gluer, S., Rosner, H., Gerardy-Schahn, R., and Rahmann, H. (1998) Polysialic acid on the neural cell adhesion molecule correlates with expression of polysialyltransferases and promotes neuroblastoma cell growth. Cancer Res., 58 (4), 779-784.
70. Lantuejoul, S., Moro, D., Michalides, R.J., Brambilla, C., and Brambilla, E. (1998) Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am. J. Surg. Pathol., 22 (10), 1267-1276.
71. Michalides, R., Kwa, B., Springall, D., van Zandwijk, N., Koopman, J., Hilkens, J., and Mooi, W. (1994) NCAM and lung cancer. Int. J. Cancer Suppl., 8, 34-37.
72. Mayanil, C.S., George, D., Mania-Farnell, B., Bremer, C.L., McLone, D.G., and Bremer, E.G. (2000) Overexpression of murine Pax3 increases NCAM polysialylation in a human medulloblastoma cell line. J. Biol. Chem., 275 (30), 23259-23266.
73. Fukuda, M. (1996) Possible roles of tumor-associated carbohydrate antigens. Cancer Res., 56 (10), 2237-2244.
74. Suzuki, M., Nakayama, J., Suzuki, A., Angata, K., Chen, S., Sakai, K., Hagihara, K., Yamaguchi, Y., and Fukuda, M. (2005) Polysialic acid facilitates tumor invasion by glioma cells. Glycobiology, 15 (9), 887-894.
75. Petridis, A.K., Wedderkopp, H., Hugo, H.H., and Maximilian Mehdorn, H. (2009) Polysialic acid overexpression in malignant astrocytomas. Acta Neurochir. (Wien), 151 (6), 601-603. discussion 603-604.
76. Yang, P., Yin, X., and Rutishauser, U. (1992) Intercellular space is affected by the polysialic acid content of NCAM. J. Cell Biol., 116 (6), 1487-1496.
77. Johnson, C.P., Fujimoto, I., Rutishauser, U., and Leckband, D.E. (2005) Direct evidence that neural cell adhesion molecule (NCAM) polysialylation increases intermembrane repulsion and abrogates adhesion. J. Biol. Chem, 280 (1), 137-145.
78. Rutishauser, U. (1996) Polysialic acid and the regulation of cell interactions . Curr. Opin. Cell Biol., 8 (5), 679-684.
79. Finne, J., and Makela, P.H. (1985) Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid. J. Biol. Chem., 260 (2), 1265-1270.
80. Pelkonen, S., Pelkonen, J., and Finne, J. (1989) Common cleavage pattern of polysialic acid by bacteriophage endosialidases of different properties and origins. J. Virol., 63 (10), 4409-4416.
81. Chung, W.W., Lagenaur, C.F., Yan, Y.M., and Lund, J.S. (1991) Developmental expression of neural cell adhesion molecules in the mouse neocortex and olfactory bulb. J. Comp. Neurol., 314 (2), 290-305.
82. Kanato, Y., Kitajima, K., and Sato, C. (2008) Direct binding of polysialic acid to a brain-derived neurotrophic factor depends on the degree of polymerization. Glycobiology, 18 (12), 1044-1053.
83. Watson, K., Edwards, R.J., Shaunak, S., Parmelee, D.C., Sarraf, C., Gooderham, N.J., and Davies, D.S. (1995) Extra-nuclear location of histones in activated human peripheral blood lymphocytes and cultured T-cells . Biochem. Pharmacol., 50 (3), 299-309.
84. Brix, K., Summa, W., Lottspeich, F., and Herzog, V. (1998) Extracellularly occurring histone H1 mediates the binding of thyroglobulin to the cell surface of mouse macrophages. J. Clin. Invest., 102 (2), 283-293.
85. Henriquez, J.P., Casar, J.C., Fuentealba, L., Carey, D.J., and Brandan, E. (2002) Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation. J. Cell Sci., 115 (Pt 10), 2041-2051.
86. Mishra, B., von der Ohe, M., Schulze, C., Bian, S., Makhina, T., Loers, G., Kleene, R., and Schachner, M. (2010) Functional role of the interaction between polysialic acid and extracellular histone H1. J. Neurosci., 30 (37), 12400-12413.
87. Robbins, J.B., McCracken, G.H. Jr, Gotschlich, E.C., Orskov, F., Orskov, I., and Hanson, L.A. (1974) Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis . N. Engl. J. Med., 290 (22), 1216-1220.
88. Rick, P., and Silver, R. (1996) Endobacterial common antigen and capsular polysaccharides, in Escherichia coli and Salmonella: Cellular and Molecular Biology (ed. F.C. Neidhardt), American Society for Microbiology, Washington, DC, pp. 104-122.
89. Roberts, I.S. (1995) Bacterial polysaccharides in sickness and in health. The 1995 Fleming Lecture. Microbiology, 141 (Pt 9), 2023-2031.
90. Vimr, E., Steenbergen, S., and Cieslewicz, M. (1995) Biosynthesis of the polysialic acid capsule in Escherichia coli K1. J. Ind. Microbiol., 15 (4), 352-360.
91. Vimr, E.R. (1992) Selective synthesis and labeling of the polysialic acid capsule in Escherichia coli K1 strains with mutations in nanA and neuB. J. Bacteriol., 174 (19), 6191-6197.
92. Troy, F.A. 2nd (1992) Polysialylation: from bacteria to brains. Glycobiology, 2 (1), 5-23.
93. Steenbergen, S.M., and Vimr, E.R. (2008) Biosynthesis of the Escherichia coli K1 group 2 polysialic acid capsule occurs within a protected cytoplasmic compartment. Mol. Microbiol., 68 (5), 1252-1267.
94. Troy, F.A. 2nd (1995) Sialobiology and the polysialic acid glycotope: occurrence, structure, function, synthesis and glycopathy, in Biology of the Sialic Acids (ed. A. Rosenberg), Plenium Press, New York, pp. 95-144.
95. Bliss, J.M., and Silver, R.P. (1997) Evidence that KpsT, the ATP-binding component of an ATP-binding cassette transporter, is exposed to the periplasm and associates with polymer during translocation of the polysialic acid capsule of Escherichia coli K1. J. Bacteriol., 179 (4), 1400-1403.
96. Nara, K., Watanabe, Y., Maruyama, K., Kasahara, K., Nagai, Y., and Sanai, Y. (1994) Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma cells. Proc. Natl. Acad. Sci. U.S.A., 91 (17), 7952-7956.
97. Sasaki, K., Kurata, K., Kojima, N., Kurosawa, N., Ohta, S., Hanai, N., Tsuji, S., and Nishi, T. (1994) Expression cloning of a GM3-specific alpha-2,8-sialyltransferase (GD3 synthase). J. Biol. Chem., 269 (22), 15950-15956.
98. Haraguchi, M., Yamashiro, S., Yamamoto, A., Furukawa, K., Takamiya, K., Lloyd, K.O., and Shiku, H. (1994) Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. Proc. Natl. Acad. Sci. U.S.A., 91 (22), 10455-10459.
99. Nakayama, J., Fukuda, M.N., Hirabayashi, Y., Kanamori, A., Sasaki, K., Nishi, T., and Fukuda, M. (1996) Expression cloning of a human GT3 synthase. GD3 AND GT3 are synthesized by a single enzyme. J. Biol. Chem., 271 (7), 3684-3691.
100. Kono, M., Yoshida, Y., Kojima, N., and Tsuji, S. (1996) Molecular cloning and expression of a fifth type of alpha2, 8-sialyltransferase (ST8Sia V). Its substrate specificity is similar to that of SAT-V/III, which synthesize GD1c, GT1a, GQ1b and GT3. J. Biol. Chem., 271 (46), 29366-29371.
101. Angata, K., Suzuki, M., McAuliffe, J., Ding, Y., Hindsgaul, O., and Fukuda, M. (2000) Differential biosynthesis of polysialic acid on neural cell adhesion molecule (NCAM) and oligosaccharide acceptors by three distinct alpha 2,8-sialyltransferases, ST8Sia IV (PST), ST8Sia II (STX), and ST8Sia III. J. Biol. Chem., 275 (24), 18594-18601.
102. Nelson, R.W., Bates, P.A., and Rutishauser, U. (1995) Protein determinants for specific polysialylation of the neural cell adhesion molecule. J. Biol. Chem., 270 (29), 17171-17179.
103. Foley, D.A., Swartzentruber, K.G., and Colley, K.J. (2009) Identification of sequences in the polysialyltransferases ST8Sia II and ST8Sia IV that are required for the protein-specific polysialylation of the neural cell adhesion molecule, NCAM. J. Biol. Chem., 284 (23), 15505-15516.
104. Inoue, S., and Inoue, Y. (2001) Developmental profile of neural cell adhesion molecule glycoforms with a varying degree of polymerization of polysialic acid chains. J. Biol. Chem., 276 (34), 31863-31870.
105. Nakata, D., and Troy, F.A. 2nd (2005) Degree of polymerization (DP) of polysialic acid (polySia) on neural cell adhesion molecules (N-CAMS): development and application of a new strategy to accurately determine the DP of polySia chains on N-CAMS. J. Biol. Chem., 280 (46), 38305-38316.
106. Lackie, P.M., Zuber, C., and Roth, J. (1994) Polysialic acid of the neural cell adhesion molecule (N-CAM) is widely expressed during organogenesis in mesodermal and endodermal derivatives. Differentiation, 57 (2), 119-131.
107. Seidenfaden, R., Gerardy-Schahn, R., and Hildebrandt, H. (2000) Control of NCAM polysialylation by the differential expression of polysialyltransferases ST8SiaII and ST8SiaIV. Eur. J. Cell Biol., 79 (10), 680-688.
108. Monti, E., Preti, A., Venerando, B., and Borsani, G. (2002) Recent development in mammalian sialidase molecular biology. Neurochem. Res., 27 (7-8), 649-663.
109. Saito, M.Y., and Yu, R.K. (1995) Biochemistry and role of sialic acids, in Biology of the Sialic Acids (ed. A. Rosenberg), Plenum Press, New York, pp. 261-313.
110. Schauer, R., Kelm, S., Reuter, G., and Roggentin, A. (1995) Biochemistry and role of sialic acids, in Biology of the Sialic Acids (ed. A. Rosenberg), Plenum Press, New York, pp. 7-67.
111. Stockert, R.J. (1995) The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev., 75 (3), 591-609.
112. Gregoriadis, G., McCormack, B., Wang, Z., and Lifely, R. (1993) Polysialic acids: potential in drug delivery. FEBS Lett., 315 (3), 271-276.
113. Gregoriadis, G., Fernandes, A., McCormack, B., Mital, M., and Zhang, X. (1999) Polysialic acids: potential role in therapeutic constructs. Biotechnol. Genet. Eng. Rev., 16, 203-215.
114. Gregoriadis, G., Fernandes, A., Mital, M., and McCormack, B. (2000) Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics . Cell. Mol. Life Sci., 57 (13-14), 1964-1969.
115. Fraser-Moodie, I. (2008) Delivery mechanisms for large molecule drugs: successes and failures of leading technologies and key drivers for market success. Business Insights Report, 2006 (Business Insights Ltd).
116. Fernandes, A.I., and Gregoriadis, G. (2001) The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics. Int. J. Pharm., 217 (1-2), 215-224.
117. Jain, S., Hreczuk-Hirst, D.H., McCormack, B., Mital, M., Epenetos, A., Laing, P., and Gregoriadis, G. (2003) Polysialylated insulin: synthesis, characterization and biological activity in vivo . Biochim. Biophys. Acta, 1622 (1), 42-49.
118. Adams, G.P., Shaller, C.C., Chappell, L.L., Wu, C., Horak, E.M., Simmons, H.H., Litwin, S., Marks, J.D., Weiner, L.M., and Brechbiel, M.W. (2000) Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules. Nucl. Med. Biol., 27 (4), 339-346.
119. Nakayama, J., Fukuda, M.N., Fredette, B., Ranscht, B., and Fukuda, M. (1995) Expression cloning of a human polysialyltransferase that forms the polysialylated neural cell adhesion molecule present in embryonic brain . Proc. Natl. Acad. Sci. U.S.A., 92 (15), 7031-7035.
120. Jacobs, C.L., Goon, S., Yarema, K.J., Hinderlich, S., Hang, H.C., Chai, D.H., and Bertozzi, C.R. (2001) Substrate specificity of the sialic acid biosynthetic pathway. Biochemistry, 40 (43), 12864-12874.
121. Kudo, M., Takayama, E., Tashiro, K., Fukamachi, H., Nakata, T., Tadakuma, T., Kitajima, K., Inoue, Y., and Shiokawa, K. (1998) Cloning and expression of an alpha-2, 8-polysialyltransferase (STX) from Xenopus laevis. Glycobiology, 8 (8), 771-777.
122. Cho, J.W., and Troy, F.A. 2nd (1994) Polysialic acid engineering: synthesis of polysialylated neoglycosphingolipids by using the polysialyltransferase from neuroinvasive Escherichia coli K1 . Proc. Natl. Acad. Sci. U.S.A., 91 (24), 11427-11431.
123. Zhang, R., Jain, S., Rowland, M., Hussain, N., Agarwal, M., and Gregoriadis, G. (2010) Development and testing of solid dose formulations containing polysialic acid insulin conjugate: next generation of long-acting insulin. J. Diabetes Sci. Technol., 4 (3), 532-539 .